Telephone: +44 (0)1223 750638
One day, I received a letter from my doctor inviting me to take part in some research. I thought “why not? I’m always dealing with the regulatory compliance side of research so let’s see what it’s like to be on the receiving end as an active participant.”
Well if you were at the network meeting on 18 November 2013 you may well know some of the answers but, if you missed it, don't worry because I was there!
The UK's MHRA has announced today that "from 30 April 2014, all manufactured herbal medicines will have to be authorised in order to be sold and supplied lawfully in the UK."
"This means that after this date herbal retailers will no longer be able to sell unlicensed herbal medicines that are not registered under the Traditional Herbal Registration (THR) scheme in the UK."
The Cambridge Network Team again excelled in delivering a network evening based on the more ‘unusual’, in this case the BLOODHOUND Project. It was great to meet such a variety of people from completely different sectors of the Cambridge Scene but all with a common interest: a fascination of the technology and engineering behind the development of a land vehicle which will exceed 1000mph. Yes, that’s right, “exceed<
The following 12 botanicals have been cited by NutraIngredients.com as ‘top’ for health benefits:
Greer Deal, Director of Global Regulatory Services (GRS) presented at the Ethics and GCP Forum organised by the Institute of Clinical Research on 4th November 2013 in London. She ran through some of the obvious, and not so obvious, regulatory pathways for launching a herbal product onto the EU market. It was a lot to cover in only 45 minutes!
The EU Commission voted on the proposed new Regulations on 22 October 2013 on the same day as the BSI Consultants' Day, so you could say it was a "Hot Topic"!
Our immediate comments are:
|Copyright © 2013 GRS All Rights Reserved||
Global House, Painters Lane, Sutton, Ely,
Cambridgeshire, CB6 2NS, UK
Telephone: +44(0)1223 750638